Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - RIGEL PHARMACEUTICALS INC | a11-9299_1ex31d1.htm |
| EX-31.2 - EX-31.2 - RIGEL PHARMACEUTICALS INC | a11-9299_1ex31d2.htm |
| EX-32.1 - EX-32.1 - RIGEL PHARMACEUTICALS INC | a11-9299_1ex32d1.htm |
| 10-Q - 10-Q - RIGEL PHARMACEUTICALS INC | a11-9299_110q.htm |
Exhibit 10.32
2011 Base Salaries for Named Executive Officers
|
Name and Title |
|
Salary |
| |
|
James M. Gower |
|
|
| |
|
Chief Executive Officer, Chairman of the Board and Director |
|
$ |
648,900 |
|
|
Donald G. Payan, M.D. |
|
|
| |
|
Executive Vice President and President of Discovery and Research |
|
$ |
522,365 |
|
|
Raul R. Rodriguez |
|
|
| |
|
President and Chief Operating Officer |
|
$ |
515,037 |
|
|
Elliott B. Grossbard, M.D. |
|
|
| |
|
Executive Vice President and Chief Medical Officer |
|
$ |
486,675 |
|
|
Ryan D. Maynard |
|
|
| |
|
Executive Vice President and Chief Financial Officer |
|
$ |
412,000 |
|